Pietro Giannitti

Agaton is an innovative company, dedicated to the development and marketing of nutraceuticals, medical devices, cosmeceuticals. Agaton selects the active ingredients extracted and purified within the European Union, from reliable and guaranteed sources. The active ingredients and excipients are then assembled according to our formulas, in a state-of-the-art facility for efficiency and quality, in order to guarantee the patient a finished product that is first of all healthy and safe. Agaton works according to the best standards required by the Italian Ministry of Health and EFSA. AGATON products are therefore defined to the medical class and pharmacists by our scientific representatives of the drug, through the correct and balanced exposure of the scientific evidence that makes it useful to take our active ingredients in certain pathologies or deficiencies. More unique than rare, Agaton makes available to its interlocutors, doctors or pharmacists, all the documentation, from the master formula to the quality certificates, which certify the purity of its products. Since 2014 Agaton has been engaged in research on new phytotherapeutic perspectives in the oncology field thanks to the support of the MIUR (Ministry of Education, University and Research) to the project "Isolation, identification and characterization of the bioactive principles of Feijoa Sellowiana". Agaton will carry out his research in collaboration with academic institutions with a high scientific profile, such as the Federico II University of Naples and the Pascale Cancer Institute.